These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 35931979)
1. Multiparametric MR radiomics in brain glioma: models comparation to predict biomarker status. He J; Ren J; Niu G; Liu A; Wu Q; Xie S; Ma X; Li B; Wang P; Shen J; Wu J; Gao Y BMC Med Imaging; 2022 Aug; 22(1):137. PubMed ID: 35931979 [TBL] [Abstract][Full Text] [Related]
2. Amide proton transfer weighted and diffusion weighted imaging based radiomics classification algorithm for predicting 1p/19q co-deletion status in low grade gliomas. Ma A; Yan X; Qu Y; Wen H; Zou X; Liu X; Lu M; Mo J; Wen Z BMC Med Imaging; 2024 Apr; 24(1):85. PubMed ID: 38600452 [TBL] [Abstract][Full Text] [Related]
3. [Prediction of 1p/19q codeletion status in diffuse lower-grade glioma using multimodal MRI radiomics]. Lu M; Qu Y; Ma A; Zhu J; Zou X; Lin G; Li Y; Liu X; Wen Z Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):1023-1028. PubMed ID: 37439176 [TBL] [Abstract][Full Text] [Related]
4. Multicenter clinical radiomics-integrated model based on [ Zhang L; Pan H; Liu Z; Gao J; Xu X; Wang L; Wang J; Tang Y; Cao X; Kan Y; Wen Z; Chen J; Huang D; Chen S; Li Y Eur Radiol; 2023 Feb; 33(2):872-883. PubMed ID: 35984514 [TBL] [Abstract][Full Text] [Related]
5. Glioma grading prediction using multiparametric magnetic resonance imaging-based radiomics combined with proton magnetic resonance spectroscopy and diffusion tensor imaging. Lin K; Cidan W; Qi Y; Wang X Med Phys; 2022 Jul; 49(7):4419-4429. PubMed ID: 35366379 [TBL] [Abstract][Full Text] [Related]
6. T2-FLAIR mismatch sign and machine learning-based multiparametric MRI radiomics in predicting IDH mutant 1p/19q non-co-deleted diffuse lower-grade gliomas. Tang WT; Su CQ; Lin J; Xia ZW; Lu SS; Hong XN Clin Radiol; 2024 May; 79(5):e750-e758. PubMed ID: 38360515 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive Evaluation of the Notch Signaling Pathway via Radiomic Signatures Based on Multiparametric MRI in Association With Biological Functions of Patients With Glioma: A Multi-institutional Study. Shen N; Lv W; Li S; Liu D; Xie Y; Zhang J; Zhang J; Jiang J; Jiang R; Zhu W J Magn Reson Imaging; 2023 Mar; 57(3):884-896. PubMed ID: 35929909 [TBL] [Abstract][Full Text] [Related]
8. Development and external validation of a multiparametric MRI-based radiomics model for preoperative prediction of microsatellite instability status in rectal cancer: a retrospective multicenter study. Li Z; Zhang J; Zhong Q; Feng Z; Shi Y; Xu L; Zhang R; Yu F; Lv B; Yang T; Huang C; Cui F; Chen F Eur Radiol; 2023 Mar; 33(3):1835-1843. PubMed ID: 36282309 [TBL] [Abstract][Full Text] [Related]
9. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas. Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598 [TBL] [Abstract][Full Text] [Related]
10. Thin-Slice Magnetic Resonance Imaging-Based Radiomics Signature Predicts Chromosomal 1p/19q Co-deletion Status in Grade II and III Gliomas. Kong Z; Jiang C; Zhang Y; Liu S; Liu D; Liu Z; Chen W; Liu P; Yang T; Lyu Y; Zhao D; You H; Wang Y; Ma W; Feng F Front Neurol; 2020; 11():551771. PubMed ID: 33192984 [No Abstract] [Full Text] [Related]
11. The efficacy of using a multiparametric magnetic resonance imaging-based radiomics model to distinguish glioma recurrence from pseudoprogression. Fu FX; Cai QL; Li G; Wu XJ; Hong L; Chen WS Magn Reson Imaging; 2024 Sep; 111():168-178. PubMed ID: 38729227 [TBL] [Abstract][Full Text] [Related]
12. MR imaging of epithelial ovarian cancer: a combined model to predict histologic subtypes. Qian L; Ren J; Liu A; Gao Y; Hao F; Zhao L; Wu H; Niu G Eur Radiol; 2020 Nov; 30(11):5815-5825. PubMed ID: 32535738 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Radiomics Analyses Based on Different Magnetic Resonance Imaging Sequences in Grading and Molecular Genomic Typing of Glioma. Huang WY; Wen LH; Wu G; Hu MZ; Zhang CC; Chen F; Zhao JN J Comput Assist Tomogr; 2021 Jan-Feb 01; 45(1):110-120. PubMed ID: 33475317 [TBL] [Abstract][Full Text] [Related]
14. Impact of signal intensity normalization of MRI on the generalizability of radiomic-based prediction of molecular glioma subtypes. Foltyn-Dumitru M; Schell M; Rastogi A; Sahm F; Kessler T; Wick W; Bendszus M; Brugnara G; Vollmuth P Eur Radiol; 2024 Apr; 34(4):2782-2790. PubMed ID: 37672053 [TBL] [Abstract][Full Text] [Related]
15. Multi-parametric Z-spectral MRI may have a good performance for glioma stratification in clinical patients. Su C; Xu S; Lin D; He H; Chen Z; Damen FC; Ke C; Lv X; Cai K Eur Radiol; 2022 Jan; 32(1):101-111. PubMed ID: 34272981 [TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging-based radiomics analysis of the differential diagnosis of ovarian clear cell carcinoma and endometrioid carcinoma: a retrospective study. Takeyama N; Sasaki Y; Ueda Y; Tashiro Y; Tanaka E; Nagai K; Morioka M; Ogawa T; Tate G; Hashimoto T; Ohgiya Y Jpn J Radiol; 2024 Jul; 42(7):731-743. PubMed ID: 38472624 [TBL] [Abstract][Full Text] [Related]
17. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas. Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822 [TBL] [Abstract][Full Text] [Related]
18. Whole-Tumor Histogram Analysis of Multiple Diffusion Metrics for Glioma Genotyping. Gao A; Zhang H; Yan X; Wang S; Chen Q; Gao E; Qi J; Bai J; Zhang Y; Cheng J Radiology; 2022 Mar; 302(3):652-661. PubMed ID: 34874198 [TBL] [Abstract][Full Text] [Related]
19. Predicting IDH subtype of grade 4 astrocytoma and glioblastoma from tumor radiomic patterns extracted from multiparametric magnetic resonance images using a machine learning approach. Kandalgaonkar P; Sahu A; Saju AC; Joshi A; Mahajan A; Thakur M; Sahay A; Epari S; Sinha S; Dasgupta A; Chatterjee A; Shetty P; Moiyadi A; Agarwal J; Gupta T; Goda JS Front Oncol; 2022; 12():879376. PubMed ID: 36276136 [TBL] [Abstract][Full Text] [Related]
20. Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas. Jiang C; Kong Z; Zhang Y; Liu S; Liu Z; Chen W; Liu P; Liu D; Wang Y; Lyu Y; Zhao D; Wang Y; You H; Feng F; Ma W Neuroradiology; 2020 Jul; 62(7):803-813. PubMed ID: 32239241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]